Christian Sander Danstrup1,2,3, Nina Munk Lyhne4,5, Adrienn Kovacsne6, Rune Fisker6, Helle Damgaard Zacho5,7,6. 1. Department of Otorhinolaryngology - Head and Neck Surgery, Aalborg University Hospital, Aalborg, Denmark. csd@rn.dk. 2. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. csd@rn.dk. 3. Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark. csd@rn.dk. 4. Department of Otorhinolaryngology - Head and Neck Surgery, Aalborg University Hospital, Aalborg, Denmark. 5. Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. 6. Department of Nuclear Medicine, Aalborg University Hospital, Aalborg, Denmark. 7. Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
Abstract
PURPOSE: We aimed to evaluate the frequency and malignancy rate of incidental salivary gland lesions (ISGLs) in patients undergoing 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT). METHODS: Using a predefined algorithm, all descriptions of FDG-PET/CT scans performed in the North Denmark Region at the Department of Nuclear Medicine, Aalborg University Hospital from 1.12 2009 to 31.12 2019 were electronically searched for focal uptake in one or more salivary glands. RESULTS: In total, 28,362 FDG-PET/CT scans were performed in the study period. ISGLs were found in 197 (0.7%). A total of 193 (98%) had parotid gland ISGL, and four (2%) had submandibular ISGL. No sublingual lesions were found. Ultimately, 117 patients (60%) were referred to the Department of Otorhinolaryngology-Head and Neck Surgery for evaluation. Fine needle aspiration biopsy was performed in 97 patients, and the most frequent cytopathology was Warthin's tumour (n = 62). Two patients had verified malignancy: one with histopathologically proven acinic cell carcinoma and one with cytopathologically proven metastasis from an oral squamous cell carcinoma. CONCLUSIONS: Incidental salivary gland findings on FDG-PET/CT are rare, and the risk of malignancy is low. Patients with ISGL may be evaluated secondary to the primary disease, but special attention should be given to patients with prior or known head-and-neck malignancies and patients with symptoms from the salivary glands, including swelling.
PURPOSE: We aimed to evaluate the frequency and malignancy rate of incidental salivary gland lesions (ISGLs) in patients undergoing 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT). METHODS: Using a predefined algorithm, all descriptions of FDG-PET/CT scans performed in the North Denmark Region at the Department of Nuclear Medicine, Aalborg University Hospital from 1.12 2009 to 31.12 2019 were electronically searched for focal uptake in one or more salivary glands. RESULTS: In total, 28,362 FDG-PET/CT scans were performed in the study period. ISGLs were found in 197 (0.7%). A total of 193 (98%) had parotid gland ISGL, and four (2%) had submandibular ISGL. No sublingual lesions were found. Ultimately, 117 patients (60%) were referred to the Department of Otorhinolaryngology-Head and Neck Surgery for evaluation. Fine needle aspiration biopsy was performed in 97 patients, and the most frequent cytopathology was Warthin's tumour (n = 62). Two patients had verified malignancy: one with histopathologically proven acinic cell carcinoma and one with cytopathologically proven metastasis from an oral squamous cell carcinoma. CONCLUSIONS: Incidental salivary gland findings on FDG-PET/CT are rare, and the risk of malignancy is low. Patients with ISGL may be evaluated secondary to the primary disease, but special attention should be given to patients with prior or known head-and-neck malignancies and patients with symptoms from the salivary glands, including swelling.
Authors: Yavuz Anacak; Robert C Miller; Nikos Constantinou; Angela M Mamusa; Ron Epelbaum; Yexiong Li; Anna Lucas Calduch; Anna Kowalczyk; Damien C Weber; Sidney P Kadish; Nuran Bese; Philip Poortmans; Serra Kamer; Mahmut Ozsahin Journal: Int J Radiat Oncol Biol Phys Date: 2010-11-13 Impact factor: 7.038
Authors: Andrea Gallamini; Sally F Barrington; Alberto Biggi; Stephane Chauvie; Lale Kostakoglu; Michele Gregianin; Michel Meignan; George N Mikhaeel; Annika Loft; Jan M Zaucha; John F Seymour; Michael S Hofman; Luigi Rigacci; Alessandro Pulsoni; Morton Coleman; Eldad J Dann; Livio Trentin; Olivier Casasnovas; Chiara Rusconi; Pauline Brice; Silvia Bolis; Simonetta Viviani; Flavia Salvi; Stefano Luminari; Martin Hutchings Journal: Haematologica Date: 2014-03-21 Impact factor: 9.941
Authors: Sally F Barrington; N George Mikhaeel; Lale Kostakoglu; Michel Meignan; Martin Hutchings; Stefan P Müeller; Lawrence H Schwartz; Emanuele Zucca; Richard I Fisher; Judith Trotman; Otto S Hoekstra; Rodney J Hicks; Michael J O'Doherty; Roland Hustinx; Alberto Biggi; Bruce D Cheson Journal: J Clin Oncol Date: 2014-09-20 Impact factor: 44.544
Authors: Marc C Mabray; Spencer C Behr; David M Naeger; Robert R Flavell; Christine M Glastonbury Journal: Clin Imaging Date: 2015-07-16 Impact factor: 1.605
Authors: Miguel Gallach; Miriam Mikhail Lette; May Abdel-Wahab; Francesco Giammarile; Olivier Pellet; Diana Paez Journal: Med Sci Monit Date: 2020-08-27